首页> 外文期刊>Iranian red crescent medical journal >Effects of Acellular Amniotic Membrane Matrix and Bone Marrow-Derived Mesenchymal Stem Cells in Improving Random Skin Flap Survival in Rats
【24h】

Effects of Acellular Amniotic Membrane Matrix and Bone Marrow-Derived Mesenchymal Stem Cells in Improving Random Skin Flap Survival in Rats

机译:脱细胞羊膜基质和骨髓源性间充质干细胞在改善大鼠随机皮瓣存活中的作用

获取原文
           

摘要

The necrotic skin flap represents a great challenge in plastic and reconstructive surgery. In this study, we evaluated the effect of bioscaffolds, acellular amniotic membranes (AAMs), and bone marrow-derived mesenchymal stem cells (BM-MSCs) on random skin flap (RSF) survival in rats by applying a cell-free extracellular matrix scaffold as a supportive component for the growth and proliferation of BM-MSCs on RSFs. AAM matrix scaffolds were created by incubating AMs in ethylenediaminetetraacetic acid 0.05% at 37°C, and cell scrapers were used. Objectives: The aim of the present study was to assess the effect of AAM as a scaffold in TE, and combined with transplanted BM-MSCs, on the survival of RSFs and on the biomechanical parameters of the incision-wound flap margins 7 days after flap elevation. Materials and Methods: BM-MSCs and AAMs were transplanted into subcutaneous tissue in the flap area. On the 7th postoperative day, the surviving flap areas were measured using digital imaging software, and the flap tissue was collected for evaluation. Forty rats were randomly divided into four groups of 10 each: group 1 received an AAM injection; group 2 underwent BM-MSC transplantation; group 3 received both AAM injection + BM-MSC transplantation; and group 4 was the control group, receiving only saline. Results: The survival area in the AAM/BM-MSC group was significantly higher than in the control group (18.49 ± 1.58 versus 7.51 ± 2.42, P < 0.05). The biomechanical assessment showed no significant differences between the experimental groups and the control group (P > 0.05), and there was no correlation with flap survival. Conclusions: Our findings showed that the treatment of flaps with BM-MSC and AAM transplantations significantly promoted flap survival compared to a control group. The viability of the flap was improved by combining BM-MSCs with AAM matrix scaffolds.
机译:坏死的皮瓣代表了整形和重建手术中的巨大挑战。在这项研究中,我们通过应用无细胞的细胞外基质支架,评估了生物支架,脱细胞羊膜(AAM)和骨髓源性间充质干细胞(BM-MSC)对大鼠随机皮瓣(RSF)存活的影响。作为BM-MSC在RSF上生长和增殖的支持成分。通过将AM在0.05%的乙二胺四乙酸中于37°C孵育来创建AAM基质支架,并使用细胞刮刀。目的:本研究的目的是评估AAM作为TE的支架,并结合移植的BM-MSC,对RSF的存活率以及皮瓣术后7天切口创皮瓣边缘的生物力学参数的影响海拔。材料与方法:将BM-MSC和AAM移植到皮瓣区域的皮下组织中。术后第7天,使用数字成像软件测量皮瓣存活面积,并收集皮瓣组织进行评估。 40只大鼠随机分为四组,每组10只。第2组接受BM-MSC移植;第3组接受AAM注射+ BM-MSC移植。而第4组是对照组,仅接受生理盐水。结果:AAM / BM-MSC组的生存面积显着高于对照组(18.49±1.58对7.51±2.42,P <0.05)。生物力学评估显示实验组与对照组之间无显着差异(P> 0.05),并且与皮瓣存活率无相关性。结论:我们的研究结果表明,与对照组相比,BM-MSC和AAM移植治疗皮瓣可显着提高皮瓣存活率。通过将BM-MSC与AAM基质支架相结合,改善了皮瓣的生存能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号